IMMUNE AND CYTOKINE STATUS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING ALEMTUZUMAB
In present work, we studied cytokine levels and performed analysis of some immunologic parameters in the patients with chronic lymphocytic leukemia (CLL) before and after treatment with monoclonal anti-CD52 antibody (alemtuzumab). In comparison with a control group, the CLL patients before alemtuzum...
Enregistré dans:
Auteurs principaux: | , , , , |
---|---|
Format: | article |
Langue: | RU |
Publié: |
SPb RAACI
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d104345a4c674536b7bed7af0f268234 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|